Form 4 for IBRX ImmunityBio, Inc.
Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-22 · accession 0001848899-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | 2026-02-22 | IBRX | Sachs David C. | CFO | F - Tax | $8.70 | -20.7K | 300.1K | -6% | -$179.9K |
| D | 2026-02-24 | 2026-02-22 | IBRX | Sachs David C. | CFO | M - OptEx | $0.00 | +40.6K | 320.8K | +15% | $0 |
| D | 2026-02-24 | 2026-02-22 | IBRX | Sachs David C. | CFO | M - OptEx | $0.00 | -40.6K | 40.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-22 | F | D | 20,682 | $8.70 | 300,143 | D | — | — | (F2) On February 22, 2026, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 20, 2026 was the settlement price used to calculate the shares withheld. |
| 2 | Common | Common Stock | 2026-02-22 | M | A | 40,650 | $0.00 | 320,825 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. (the "Issuer") common stock. |
| 3 | Derivative | Restricted Stock Units | 2026-02-22 | M | D | 40,650 | $0.00 | 40,651 | D | — · — to — | 40,650 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. (the "Issuer") common stock. (F3) Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024. |